Whitaker Foundation Supports Growing Multidisciplinary Biomedical Research

A quick walk through any hospital or biomedical research center clearly shows how interconnected medicine and engineering have become in the last couple of decades. Drug delivery systems (such as implantable, self-regulating insulin pumps), artificial implants (composed of new-age alloys and plastics), and imaging systems (for mapping blood flow and monitoring cell growth) all rely on the marriage of biomedicine and engineering. But the marriage of these two broad fields isn't always blissful.

Written byAngela Martello
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

A quick walk through any hospital or biomedical research center clearly shows how interconnected medicine and engineering have become in the last couple of decades. Drug delivery systems (such as implantable, self-regulating insulin pumps), artificial implants (composed of new-age alloys and plastics), and imaging systems (for mapping blood flow and monitoring cell growth) all rely on the marriage of biomedicine and engineering. But the marriage of these two broad fields isn't always blissful.

"Engineers don't know biochemistry, and biochemists don't know engineering," says Lee Huntsman, director of the Center for Bioengineering at the University of Washington in Seattle. But, he notes, bioengineering has become an "attractive discipline" for incoming graduate students with engineering backgrounds. In the past, he says, people with degrees in chemical engineering, biochemistry, and even electrical engineering have migrated into the field of biomedical engineering.

All those scientists and engineers flocking to biomedical engineering will be happy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies